Duopharma Biotech Announces 1 for 3 Bonus Issue After Sterling 1st Quarter 2021
➢ The 1-for-3 proposed bonus issue would entail the issuance of up to 239,926,896 new
ordinary shares
➢ 1Q 2021 PBT leaps to RM23.18 million, soaring more than 30% from the RM17.73 million
posted in the preceding year corresponding period
➢ Record profits posted on back of increased quarterly revenue of RM166.45 million (2020:
RM158.71 million)